Back to top
more

Alcon (ALC)

(Real Time Quote from BATS)

$92.53 USD

92.53
860,993

-0.08 (-0.09%)

Updated Nov 11, 2024 02:56 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 250)

Industry: Medical - Instruments

Zacks News

Haemonetics (HAE) Rides on Plasma Arm Recovery Amid COVID Woes

Haemonetics' (HAE) hospital business is recovering primarily driven by continued improvement in hospital procedures.

QIAGEN (QGEN) to Boost NeuMoDx Production With US DOD Contract

QIAGEN's (QGEN) NeuMoDx platforms offer a unique combination of speed, flexibility, throughput and ease of use for molecular diagnostics testing, including laboratory-developed tests.

Here's Why You Should Hold on to Thermo Fisher (TMO) for Now

Investors are optimistic about Thermo Fisher (TMO) on strength in end markets and raised 2021 guidance.

Alcon's (ALC) Robust Product Line, Market Rebound Aid Growth

In Presbyopia-correcting Intraocular Lens (PCIOLs), Alcon (ALC) currently leads the market with over 55% of global share and over 80% share in the United States.

Hologic (HOLX) Adds New Products to Omni Hysteroscopy Offering

Hologic (HOLX) expands Omni suite in EMEA with the new Omni 30 degree hysteroscope, Omni Lok cervical seal and Omni 5 French seal products.

Illumina (ILMN) Oncology Growth Aids Amid GRAIL Merger Hurdle

Illumina (ILMN) is making progress outside the United States to ensure all expecting families have access to NIPT.

Thermo Fisher (TMO) Launches Kit for Safer Sample Collection

Thermo Fisher (TMO) launches SpeciMAX Stabilized Saliva Collection Kit that can support global efforts toward SARS-CoV-2 research by ensuring safer saliva collection.

Globus Medical (GMED) Progresses With ExcelsiusGPS in DBS

According to Globus Medica (GMED), the clinical superiority of ExcelsiusGPS continues to be recognized by surgeons.

Orthofix (OFIX) Reaches Milestone for M6-C Disc Implants

Orthofix (OFIX) reveals that more than 60,000 M6-C artificial cervical discs have been implanted worldwide.

NEOGEN (NEOG) Igenity Branded Calves Score Highest US Sales

NEOGEN's (NEOG) Igenity-tested calves earn an average premium of over $59 in the summer selling season.

    Thermo Fisher's (TMO) Delta Q IRMS to Back Sustainable Science

    Thermo Fisher (TMO) has introduced the new Delta Q IRMS under the IsoFootprint campaign to support sustainable science by eliminating carbon dioxide emission.

      Here's Why You Should Add Alcon Stock (ALC) to Your Portfolio

      Investors continue to be optimistic about Alcon (ALC) backed by robust second-quarter performance and raised 2021 outlook.

      The Zacks Analyst Blog Highlights: Alcon, National Vision, The Cooper Companies and EyePoint Pharma

      The Zacks Analyst Blog Highlights: Alcon, National Vision, The Cooper Companies and EyePoint Pharma

      Riya Anand headshot

      4 Stocks to Keep a Watch on Amid Growing Optical Care Demand

      Stocks like Alcon (ALC), National Vision (EYE), The Cooper Companies (COO) and EyePoint Pharmaceuticals (EYPT) are gaining momentum amid rising optical care demand.

      Alcon (ALC) Q2 Earnings Top Estimates, 2021 Guidance Up

      Alcon (ALC) records the highest sales in the second quarter of 2021 since its spin-off.

      Alcon (ALC) to Report Q2 Earnings: What's in the Cards?

      Continued strength in the Surgical segment and new launches under Vision Care segment are likely to have driven growth in the second quarter for Alcon (ALC).

      Urmimala Biswas headshot

      3 Medical Instruments Stocks Countering Industry Headwinds

      The Zacks Medical - Instruments industry is growing on base business recovery. ISRG, IDXX and ALC are set to gain the most. However, falling demand for COVID-19 tests might disrupt the trend.

      Co-Diagnostics (CODX) to Post Q2 Earnings: What's in Store?

      Co-Diagnostics' (CODX) second-quarter results are likely to reflect higher COVID-19 test sales.

      New Strong Sell Stocks for June 2nd

      Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

      Mitchell Moore headshot

      Should You Pick Up Novartis (NVS) Before Q2 Earnings?

      Novartis AG (NVS) gained 1.1% so far in trading this week. Plus, the Swiss multinational pharmaceutical company has been on a tear since the end of April, up 18.2%. Now let's see what investors should expect heading into its Q2 2019 earnings release on Thursday.